https://www.taxtmi.com/caselaws?id=346282 The Tribunal upheld the exclusion of Pfizer Ltd. and Celestial Labs Ltd. as comparables, citing related party transactions and differing business activities. The Tribunal directed the Assessing Officer to adhere to the Dispute Resolution Panel's instructions fully. The treatment of software license fees as revenue expenditure was remanded back to the DRP for proper adjudication. The appeal by the Revenue was dismissed, while the assessee's appeal was allowed for statistical purposes. en-us Wed, 03 May 2017 00:00:00 +0530 Tue, 08 Aug 2017 08:57:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=346282 The Tribunal upheld the exclusion of Pfizer Ltd. and Celestial Labs Ltd. as comparables, citing related party transactions and differing business activities. The Tribunal directed the Assessing Officer to adhere to the Dispute Resolution Panel's instructions fully. The treatment of software license fees as revenue expenditure was remanded back to the DRP for proper adjudication. The appeal by the Revenue was dismissed, while the assessee's appeal was allowed for statistical purposes. Case-Laws Income Tax Wed, 03 May 2017 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=346282